ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,402Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 1269

$647K Total Retail Price of All Prescriptions

Rank: 68 out of 1269

296 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 296 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 296 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 11,001 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
FUROSEMIDE 509 475 1 5
DONEPEZIL HCL 391 391 2 22
SIMVASTATIN 373 327 3 3
LISINOPRIL 339 290 4 1
AMLODIPINE BESYLATE 324 304 5 2
OMEPRAZOLE 296 260 6 8
LEVOTHYROXINE SODIUM 287 243 7 4
POTASSIUM CHLORIDE 283 267 8 26
RANITIDINE HCL 253 226 9 27
CITALOPRAM HBR 242 215 10 21
MIRTAZAPINE 239 239 11 24
WARFARIN SODIUM 214 201 12 12
ATENOLOL 212 196 13 14
METOPROLOL TARTRATE 206 183 14 6
PRAVASTATIN SODIUM 200 178 15 11
RISPERIDONE 179 130 16 43
HYDROCHLOROTHIAZIDE 179 169 16 10
NAMENDA 172 172 18 38
METOPROLOL SUCCINATE 164 141 19 13
TRAMADOL HCL 160 140 20 16
PANTOPRAZOLE SODIUM 154 129 21 18
POLYETHYLENE GLYCOL 3350 148 146 22 50
SPIRIVA 147 144 23 64
HYDROCODONE-ACETAMINOPHEN 143 139 S3 24 20
TAMSULOSIN HCL 135 128 25 31
ISOSORBIDE MONONITRATE ER 133 131 26 63
GABAPENTIN 129 123 27 17
CARVEDILOL 121 117 28 29
METFORMIN HCL 115 84 29 9
FLUTICASONE PROPIONATE 109 80 30 40
TRAZODONE HCL 109 87 30 36
KLOR-CON M20 104 98 32 60
LANTUS 101 85 33 39
LOSARTAN POTASSIUM 100 95 34 15
PREDNISONE 97 95 35 45
ALLOPURINOL 89 89 36 49
DIGOXIN 87 87 37 62
HUMALOG 85 73 38 109
CLOPIDOGREL 84 83 39 32
CARBIDOPA-LEVODOPA 82 82 40 78
ADVAIR DISKUS 80 55 41 46
CYMBALTA 78 66 42 70
DIVALPROEX SODIUM 77 40 43 54
NEXIUM 77 62 43 41
QUETIAPINE FUMARATE 75 63 45 53
BUSPIRONE HCL 72 72 46 135
NOVOLOG 68 63 47 82
LACTULOSE 65 45 48 67
ESCITALOPRAM OXALATE 64 60 49 58
FLUOXETINE HCL 63 37 50 83
AZITHROMYCIN 63 56 50 42
CIPROFLOXACIN HCL 61 55 52 66
CLONIDINE HCL 61 61 52 51
JANUVIA 60 60 54 74
LOSARTAN-HYDROCHLOROTHIAZIDE 59 59 55 59
PLAVIX 59 59 55 47
SERTRALINE HCL 56 43 57 23
GLYBURIDE 53 53 R 58 94
DOXAZOSIN MESYLATE 52 52 59 117
ABILIFY 52 52 59 169
GLIMEPIRIDE 52 52 59 57
ROPINIROLE HCL 51 47 62 151
CEPHALEXIN 50 44 63 113
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.